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ABSTRACT
Objective: To identify the incidence of Ventilator-Associated Pneumonia (VAP) in hospitalized patients in an 
intensive care unit. Method: This is a cross-sectional, documentary and retrospective study. Data were collected 
through research of the records of the Service of Infection Control Related to Health Care from August 2014 
to March 2015 after approval by the Ethics Committee of the UFFS with CAEE 45124915100005564. It was 
tabulated in Excel and analyzed using descriptive and analytical statistics with the SPSS 20.0 software. Results: 
It was verified an incidence of 29% of VAP, especially the Staphylococcuss, in the tracheal aspirate and mortality 
of 44%. Conclusion: Indices consistent with data from other studies and the ones advocated by ANVISA were 
revealed. However, training for professionals involved in the care is suggested. 
Descriptors: Intensive Care Unit (ICU); Nursing; Pneumonia Associated with Mechanical Ventilation.
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RESUMO
Objetivo: Identificar a incidência de pneumonia associada à ventilação 
mecânica (PAV) em usuários hospitalizados em uma Unidade de Terapia 
Intensiva (UTI). Método: Trata-se de um estudo transversal, documental 
e retrospectivo. Os dados foram coletados por meio de busca nas fichas do 
Serviço de Controle de Infecções Relacionadas à Assistência à Saúde no 
período de agosto de 2014 a março de 2015 após aprovação no Comitê de 
Ética em Pesquisa da Universidade Federal da Fronteira Sul (UFFS) com 
CAAE nº 45124915100005564. Tabulados no programa Excel e analisados 
por meio de estatística descritiva e analítica, com o auxílio do software 
SPSS 20.0. Resultados: Evidenciaram-se incidência de 29% de PAV, com 
destaque para o Staphylococcuss no aspirado traqueal e mortalidade 
de 44%. Conclusão: Revelaram-se índices compatíveis com dados de 
outros estudos e com o preconizado pela Agência Nacional de Vigilância 
Sanitária (Anvisa). No entanto, sugestiona-se capacitação aos profissionais 
envolvidos no cuidado. 
Descritores: UTI, Enfermagem, Pneumonia associada à ventilação 
mecânica.
RESUMEN
Objetivo: Identificar laincidencia de neumonía asociada a laventilación 
mecánica (NAV) en pacientes hospitalizados en una unidad de cuidados 
intensivos. Método: Se trata de una sección transversal, documental y 
retrospectivo. Los datos fueron recolectados a través de La búsqueda de los 
registros Del Servicio de Control de Infecciones Relacionadas Cuidado de La 
Salud de agosto 2014 a marzo 2015, previa aprobación del Comité de Ética 
de La UFFS con CAEE 45124915100005564. En forma de tabla en Excel y se 
analizaron utilizando estadística descriptiva y analítica conel software SPSS 
20.0. Resultados: La incidência Mostró del 29% de La Neumonía Asociada 
al Ventilador, especialmente El Staphylococcussen aspirado traqueal y 
lamortalidaddel 44%. Conclusión: Revelado índices consistentes com los datos 
de otros estudios y las recomendaciones de la Anvisa. Sin embargo, sugiere La 
formación de los profesionales implicados em La atención. 
Descriptores: UTI, Enfermería, La neumonía asociada a la ventilación 
mecânica.
INTRODUCTION
The Intensive Care Unit (ICU) is the place to assist 
patients with systemic instability, risk of death and greater 
complexity, having adequate human and material resources 
to provide care to the individuals allocated.
In the context of intensive therapy, the various 
technologies employed, the highly invasive procedures, the 
health conditions of the individuals associated to the high 
manipulation of the patients by the nursing team and other 
health professionals can trigger adverse occurrences and 
serious damages to the physical integrity of the individual 
when proper monitoring is not performed.
Among the main risks to which users are exposed, there 
are the Health Care Associated Infections (HAI), currently 
representing a concern that does not only preoccupies the 
competent bodies, but a social, ethical and legal problem 
in the face of implications on the users’ lives and the risks 
to which they are subjected. According to the Ordinance of 
the Ministry of Health number 2616 of 1998, HAI are those 
acquired after the admission of a user, manifesting during 
hospitalization or after discharge, as long as they can be 
related to the hospitalization or hospital procedures.1-2
Among these infections, we can mention the mechanical 
Ventilation- Associated Pneumonia (VAP), which is 
attributed to the effects of ventilation and pulmonary 
inflammation that does not exist or is not incubated at the 
time of hospitalization. It occurs after 48 hours of mechanical 
ventilation or is diagnosed within 72 hours after extubation.3
VAP affects approximately 8% to 28% of users in invasive 
ventilatory support, and the associated mortality can exceed 
50%. We can divide the VAP into two categories, early onset 
and late onset, usually affecting users already colonized 
by microorganisms acquired at the hospital, which are 
sometimes multiresistant.4-5
In view of the above, this study aimed to identify the 
incidence of Pneumonia Associated with Mechanical 
Ventilation in a general Intensive Care Unit. 
METHOD
This is a cross-sectional, documentary retrospective-
collection survey, since it involved collecting data in a single 
period of time.6
The study site was a general ICU. The sample comprised 
100% of the records of the Service of Infection Control 
Related to HealthCare (SICRH) related to the control of the 
VAP from August 2014 to March 2015, in accordance with 
the inclusion criterion: complete record and without erasure. 
The data collection was performed by the researcher and 
comprised the month of July 2015, totalizing a quantitative 
of N-333 active search files analyzed.
For analysis, the data contained in the indicators forms 
were tabulated in the Excel program to obtain frequencies 
and percentages. We also used the IBM SPSS software 
(StatisticalPackage for the Social Sciences) version 20.0 for 
analytical treatment. Statistical tests were performed using 
Pearson’s correlation and Bivariate analysis to determine the 
significance of the variables. A significance level of 95% was 
determined, with a margin of error of 5%.
For the execution of this study, the legal and ethical 
requirements were fulfilled. Therefore, the project was sent 
to the UFFS Research Ethics Committee for assessment 
and opinion and was approved under the opinion number 
1,098,313.
RESULTS AND DISCUSSION
Figure 1 – VAP incidence in hospitalized users in an adult ICU 
from August 2014 to March 2015.
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Figure 2 – Relation between MV and permanence time in 
the ICU of patients hospitalized in an adult ICU from August 
2014 to March 2015.
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Figure 3 – Prevalent microorganisms in the tracheal aspirate 
of patients hospitalized in an adult ICU from August 2014 to 
March 2015.
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Source: SOUZA, Gabriela de Nardi. Data collection, Chapecó, 2015.
Figure 4 – VAP-associated mortality of users hospitalized in 
an adult ICU from August 2014 to March 2015.
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Source: SOUZA, Gabriela de Nardi. Data collection, Chapecó, 2015.
From the total number of users who used mechanical 
ventilation and contracted VAP, an average of 15.34 days in 
VM with ICU permanence time of 17.28 days was obtained.
VAP is the most common nosocomial infection in the 
Intensive Care setting. Its prevalence is variable, ranging from 
6 to 50 cases per 100 admissions in the ICU. Its development 
has significant morbidity, which prolongs the user time in 
mechanical ventilation, as well as the permanence time in the 
unit and all the costs related to this period of hospitalization.7
VAP has incidence rates ranging from 9% to 67%, in 
addition to prolonging the duration of MV and increasing 
the days of ICU permanence time, implying in treatment 
costs and mortality over 50% of the cases.8
VAP is directly related to ICU permanence time and 
mechanical ventilation, with a risk of developing 1 to 3% for 
each day of ventilator stay.9
Authors have pointed out significant indices of this 
clinical condition in the most diverse hospital institutions. A 
study carried out in 2011, in the state of Santa Catarina, with 
29 users, presented an incidence of 25.4% of VAP.10
A survey conducted in a public hospital in Rio de 
Janeiro, between 2006 and 2007, with 233 users, also showed 
an incidence of 25% of VAP throughout the follow-up of 
the study.11
A study carried out in 2006 with evaluation of 462 users 
on mechanical ventilation showed an incidence of VAP in 
18.8% (n-87) with mortality of 46%.12
The incidence of VAP can vary according to the 
population and available diagnostic methods, establishing 
as attack rate 3% per day in the first 5 days and 2% for each 
subsequent day.13
The present study showed better results than those 
suggested by ANVISA and close to the standards presented 
in other hospital institutions.
The monitoring of this index is important because it 
is one of the indicators of the care quality provided by the 
health service, being associated with the longer periods of 
hospitalization in the Intensive Care Units, increased costs 
and the appearance of other nosocomial complications and 
mortality.
The impact of this infection is the prolongation of the 
hospitalization time in about 12 days and the cost increase 
around 40,000 dollars per episode.13
These data emphasize the need for qualified health 
teams that excel in the quality of care offered since the 
establishment of the criteria for the establishment of the 
MV, permanence time, and the management and use of 
bundles to avoid VAP.
Considering the mortality of the surveyed users who 
developed VAP, 44% died, with a statistical significance of 
p = 0.01 between these two factors.13Mortality associated 
with MV ranges between 20 and 60%, reflecting the severity 
of the underlying diseases, organ failure and the etiological 
agent involved. If it is related to VAP, it is considered the 
leading cause of death from hospital acquired infections with 
mortality rates of up to 76%.14
Other studies have shown the mortality related to VAP 
between 20 and 70% according to the studied population.9A 
study carried out, evaluating 439 users in 361 ICUs from 20 
countries, including Brazil, revealed a mortality rate of 38%.12
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Research developed in the city of Fortaleza, in 2011, 
with 74 users, presented an incidence of VAP of 60% and 
associated mortality of 32.6%.15
Statistically correlating the cases of VAP with the 
incidence of mortality in a study conducted in the University 
Hospital of Londrina in the period from 2009 to 2011, an 
associated mortality of 68.5% was obtained.16
In the study in focus, the mortality rate associated with 
VAP is compatible with ANVISA records, however, the 
inquiry files provided by SICRH suggest underreporting of 
VAP due to lack of diagnostic criteria, masking its incidence. 
Such context reveals that mortality associated with VAP may 
also have an incidence higher than the 44% described above 
due to such factors.
In relation to microbial agents, they are caused by 
bacteria, which vary according to the type of user, the 
hospitalization permanence time, the diagnostic method 
and the use of previous antibiotic therapy.
Several studies have reported aerobic gram negative 
bacilli as responsible for approximately 60% of the cases, 
among them Pseudomonasaeruginosa, Escherichia coli, 
Klebsiellapenumoniae, Enterobacter and some species 
of the genus Acinetobacter. Of the gram positive group, 
Staphylococcus aureus affects 20% of the cases.8
The main causes of VAP are: Staphylococcus aureus, 
Pseudomonasaeruginosa and Enterobactercloacae, differing 
according to the type of user, permanence time in the unit 
and antimicrobial therapy.17
Colonization of the oral cavity is one of the intervening 
factors for the establishment of VAP because, in critical 
users, the oral microbiota becomes predominantly 
occupied by gram-negative organisms. Bacteria usually 
responsible for establishing VAP, such as P. aeruginosa, S. 
aureus methicillin resistant, Acinetobacter spp.,Escherichia 
coli, Klebsiellapneumoniae, eS. pneumoniae, are not 
commonly found in the oral cavity, but colonize this 
region in some situations, such as during hospitalization 
in the ICU.18
According to other studies, the obtained data show 
that in 20% of VAP cases, the etiological agent is the 
Staphylococcus aureus, followed by Klebsiellapneumoniae 
and Candidaalbicans, in addition to the occurrence of 
colonization by more than one microorganism.
In a study carried out in Rio de Janeiro, in a private 
hospital ICU, the most frequently isolated germs were 
Acinetobacter baumanni (28%), Pseudomonasaeruginosa 
(19%) and Staphylococcus aureus (20%); And 16% of the 
washes presented negative culture.11
Research developed in Uberlândia, in the year 2013, 
revealed that, among the studied users who developed 
VAP, 12.3% had polymicrobial etiology and 87.7% was 
caused by a single microorganism. It should also be 
considered that the evolution for VAP in individuals 
previously colonized by S. aureus was 5.5%, rather than 
1.8% for those not colonized.9
The three microorganisms prevalent, except 
Klebsiellapneumoniae, are microorganisms that reside in the 
human microbiota that, due to the clinical situation, became 
pathogenic, according to the results of this study. It is also 
convenient to establish the relationship that neither is a 
resident microorganism of the respiratory tract, that is, they 
were inoculated at this site or even colonized it due to the 
user immunosuppression.
Regarding treatment, antimicrobial use should not wait 
for culture results, but should be based on clinical-laboratory 
and radiological data, and the culture result should be used 
to adjust empirically initiated treatment.14
Due to its severity, the treatment of VAP should be initiated 
as early as possible, using broad spectrum antimicrobials until 
the results of the culture are available, as they may be several 
bacterial agents or even multi-resistant bacteria.9
CONCLUSION
Regarding the incidence of VAP, the results show that the 
parameters obtained in this study are close to the standards 
mentioned by other studies that deal with this subject and by 
the one advocated by ANVISA.
The study reveals the absence of collection routines for 
the scientific and cultural tests in the intensive care unit, also 
considered as a cause of underreporting of infections. 
In addition, it provides the institution and professionals 
who work in care with data related to infection control in 
the intensive care setting, making it possible to rethink the 
assistance offered in regard to the factors that favor the 
appearance of this type of infection and the appearance in 
the cultural and oligermes.
It is emphasized that teams must establish effective 
control measures to reduce the incidence of VAPs, adding 
value to the qualification of the assistance offered.
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